Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity
Jennifer H Foster1, Melanie B Bernhardt, Patrick A Thompson
1*Baylor College of Medicine †Texas Children's Hospital, Houston, TX ‡University of North Carolina, Chapel Hill, NC.
Abstract:
We developed a bedside algorithm for individually adjusting the high-dose methotrexate (HDMTX) dose (5 g/m) given to patients with acute lymphoblastic leukemia at high risk for methotrexate toxicity. Data were reviewed for 8 patients receiving 21 cycles of HDMTX as per our algorithm. Eleven cycles began with 5 g/m, 10 cycles began with a preinfusion 20% to 25% dose reduction. Neither mean MTX AUC (2320.5±179.1 vs. 2080.4±161.7 μmol×h/L), mean Cpss (64.3±7.9 vs. 60.8±6.1 μM), nor toxicities were statistically different between groups. Our algorithm allowed the safe administration of HDMTX to patients at risk of MTX toxicities and obviated the need for preinfusion dose reduction.
More Related Videos
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Dosage Regimens: Designs and Approaches
Dosage Regimen Designs: Nomograms and Tabulations
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
IV Infusion to Oral Dosing: Conversion Methods
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...


